Inventor · London, GB

Geoffrey Guy

72Patents
34h-index
61Co-inventors
91Inventor score

Filing activity: Apr 5, 2001 → Apr 23, 2025

Most-cited inventions

PatentTitleAreaCited byStatus
US7025992B2 Pharmaceutical formulations Human Necessities 87 Expired
US9017737B2 Use of cannabinoids in combination with an anti-psychotic medicament Human Necessities 86 Active
US7622140B2 Processes and apparatus for extraction of active substances and enriched extracts from natural products Performing Operations; Transporting 85 Expired
US8673368B2 Cannabinoid-containing plant extracts as neuroprotective agents Human Necessities 78 Active
US9474726B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 69 Active
US9066920B2 Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy Human Necessities 69 Active
US9168278B2 Use for cannabinoid Human Necessities 68 Active
US9956185B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 64 Active
US9956183B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 63 Active
US9956186B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 63 Active
US10111840B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 62 Active
US9956184B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 62 Active
US6730330B2 Pharmaceutical formulations Human Necessities 62 Expired
US9522123B2 Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy Human Necessities 59 Active
US10092525B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 58 Active
US9949937B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 58 Active
US10137095B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 58 Active
US9949936B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 50 Active
US10709671B2 Use of cannabinoids in the treatment of epilepsy Performing Operations; Transporting 45 Active
US9205063B2 Cannabinoid-containing plant extracts as neuroprotective agents Human Necessities 45 Active
US10918608B2 Use of cannabidiol in the treatment of epilepsy Human Necessities 45 Active
US10849860B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 44 Active
US10709673B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 44 Active
US10709674B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 44 Active
US10603288B2 Use of cannabinoids in the treatment of epilepsy Human Necessities 44 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.